openPR Logo
Press release

Remdesivir Market Share, Demand Analysis, Growth, Trends and Forecast - 2028

04-09-2022 07:58 AM CET | Health & Medicine

Press release from: Orion Market Reports

The global remdesivir market is anticipated to grow at a CAGR of 6.0% during the forecast period (2022- 2028).

Remdesivir (RDV) is one of the promising drugs for the treatment of the COVID-19 disease. The FDA has approved an Emergency Use Authorization to allow adults and children who are hospitalized with severe COVID-19 to receive Remdesivir. Remdesivir is a broad spectrum anti-viral medication which was firstly developed by Gilead Sciences. It is administered through injection into the vein. Remdesivir is a prodrug of nucleotide. Originally remdesiver is used in the treatment of hepatitis C, Ebola virus, and Marburg virus infection.

(Get 15% Discount on Buying this Report)
A full report of Global Remdesivir Market is available at: https://orionmarketreports.com/remdesivir-market/96940/

With the rise in cases of viral infections, the surge in unhygienic practices in rural areas, the increase in demand to overcome viral infections, the surge in cases of COVID-19 across the globe, the increase in geriatric population, and the rise in hospital-acquired infections are the some of the key factors that drive the growth of the remdesivir market.

However, the shortage of remdesivir supply and availability of substitutes can restrain the growth of the market. The market is segmented based on the dosage, form, application, and distribution channel. Based on the form, the market is sub-segmented into lyophilized powder and concentrated solution. The lyophilized powder is a freeze-dried powder. This is a peptide in the form of lyophilized powder. A concentrated solution is one that has a relatively large amount of dissolved solute. It has a small amount of dissolved solute in it.

Some major players in the market include Cipla Ltd., Mylan NV, and Zydus Healthcare Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships, new product launches, and collaborations, to stay competitive in the market. For instance, in 2020, Jubilant Pharma Ltd announced the launch of Remdesivir for injection 100mg vial under the brand name JUBI-R. This injection can be used in the treatment of COVID-19. Additionally, in 2020, Mylan NV announced the commercial launch of Remdesivir for injection under the brand name DESREMTM in India. This is a licensed drug for the treatment of COVID-19 patients. In 2020, Zydus Group announced the launch of Remdesivir lyophilized injection 100mg/vial. This injection can be used for patients suffering from SARS-CoV2.

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Dosage
o By Form
o By Application
o By Distribution Channel

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Cipla Ltd., Mylan NV, and Zydus Healthcare Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Remdesivir Market Report by Segment

By Dosage
• 2.5 Mg
• 5 Mg
• 100 Mg
• 200 Mg

By Form
• Lyophilized Powder
• Concentrated Solution

By Application
• Ebola
• SARS-COV
• MERS-COV
• COVID-19

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Remdesivir Market Share, Demand Analysis, Growth, Trends and Forecast - 2028 here

News-ID: 2599063 • Views:

More Releases from Orion Market Reports

Automotive Ignition Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Automotive Ignition Market is Anticipated to Increase at a Stable CAGR over the …
Global Automotive Ignition Market is anticipated to grow at a considerable CAGR of 6% during the forecast period (2024-2031). Automotive ignition refers to the system responsible for initiating the combustion process in the internal combustion engine of a vehicle. This crucial system ensures the efficient starting and operation of the engine, allowing the vehicle to propel forward. The ignition process involves generating a spark at the spark plug, igniting the
Automotive Hydraulics Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Automotive Hydraulics Market is Anticipated to Increase at a Stable CAGR over th …
Global Automotive Hydraulics Market is anticipated to grow at a considerable CAGR of 4% during the forecast period (2024-2031). Automotive hydraulics refers to the utilization of hydraulic systems and components in vehicles to perform various functions, enhancing efficiency, safety, and overall performance. These hydraulic systems leverage the power of fluids to transmit force and control mechanisms, contributing to crucial aspects of automotive Hydraulics Market. Get Sample Copy of this Report at
Automotive Handbrake and Clutch Cables Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Automotive Handbrake and Clutch Cables Market is Anticipated to Increase at a St …
Global Automotive Handbrake and Clutch Cables Market is anticipated to grow at a considerable CAGR of 3% during the forecast period (2024-2031). Automotive handbrake and clutch cables are essential elements in vehicles, serving to operate handbrakes and clutches effectively. The handbrake cable establishes a connection between the handbrake lever or pedal and the braking mechanism, granting drivers the ability to activate the handbrake. Likewise, the clutch cable connects the clutch
Automotive Infotainments Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Automotive Infotainments Market is Anticipated to Increase at a Stable CAGR over …
Global Automotive Infotainments Market is anticipated to grow at a considerable CAGR of 6% during the forecast period (2024-2031). Automotive infotainment refers to the integration of entertainment, information, and communication systems within vehicles, enhancing the overall in-car experience for drivers and passengers. These systems encompass a wide range of features, including audio and video entertainment, navigation, connectivity, and communication functionalities. Get Sample Copy of this Report at https://orionmarketreports.com/request-sample/?id=134346 Key aspects and trends

All 5 Releases


More Releases for Remdesivir

Remdesivir Medicine Market Is Booming Worldwide with Gilead Sciences, Sanofi, Gl …
Advance Market Analytics published a new research publication on “Remdesivir Medicine Market Insights, to 2026″ with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Remdesivir Medicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Remdesivir Market Size, Opportunity Analysis, Shares & Forecast 2020-2027
Remdesivir Market report published by Value Market Research is an in-depth analysis of the market covering its size, share, value, growth and current trends for the period of 2020-2027 based on the historical data. This research report delivers recent developments of major players with their respective market share. In addition, it also delivers detailed analysis of regional and country market. The research report also covers the comprehensive profiles of the key
Remdesivir Market Size and Forecast 2021-2030 | COVID-19 Growth And Change
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The global remdesivir market is expected to grow from $1.98 billion in 2020 to $2.55 billion in 2021 at a compound annual growth rate (CAGR) of 28.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from
Remdesivir Market Size & Growth Rate, Emerging Trends, Main Vendors, and Forecas …
Remdesivir is a less popular drug for antiviral medication, which has become the first medicine approved by the FDA for treating the novel Coronavirus in May 2020. Previously, the drug Remdesivir was regarded as an investigational drug. The drug was never used to treat any disease or any medical condition. Today, the drug is being studied as a probable treatment for several diseases. In the beginning, the drug was created
Hetero Healthcare set to supply Covid-19 drug Remdesivir under brand name COVIFO …
Hetero’s group company ‘Hetero Healthcare Limited’ is all set to supply 20,000 vials of Covifor (Remdesivir)across the country. Following the approval of ‘COVIFOR’, the generic of Remdesivir by DCGI, Hetero Healthcare Limited, a group company of Heterois set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of
Remdesivir (COVID-19) Market Trends, Growth, Industry Analysis and Forecast 2025
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the corona virus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Remdesivir (COVID-19) market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and